Tag: Editorial Message

In Praise of Three Women

In Praise of Three Women

| October 1, 2021

John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM, is the Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, 2021 remains a year of transition. As this year […]

Continue Reading

The Connection Between Breast Cancer and Obesity

The Connection Between Breast Cancer and Obesity

| October 1, 2021

Christopher D. Still, DO, FACN, FACP, is the Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As you all are aware, October is breast cancer awareness month, so I thought it was […]

Continue Reading

News and Notes from the September 2021 Issue of BT

News and Notes from the September 2021 Issue of BT

| September 1, 2021

by John M. Morton, MD, MPH, MHA, FACS, FASMBS, DABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, Welcome to the September 2021 issue of Bariatric Times. We […]

Continue Reading

Weight Bias in a Weight Management Program?? You Bet!

Weight Bias in a Weight Management Program?? You Bet!

| September 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, I know I have discussed this topic before, but after hearing an excellent lecture on weight bias […]

Continue Reading

The Future of Bariatric Surgery? Three S’s

The Future of Bariatric Surgery? Three S’s

| August 1, 2021

by John M. Morton, MD, MPH, MHA, FACS, FASMBS, DABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, I was recently giving a lecture and was relating that […]

Continue Reading

What’s in your…Genes

What’s in your…Genes

| August 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, As discussed on my June editorial message, semaglutide 2.4mg was FDA approved for the treatment of obesity, […]

Continue Reading

News and Notes from the July 2021 Issue of BT

News and Notes from the July 2021 Issue of BT

| July 1, 2021

by John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, Welcome to the July 2021 issue of Bariatric Times. As […]

Continue Reading

How to Evaluate Post-pandemic Weight Regain

How to Evaluate Post-pandemic Weight Regain

| July 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, With the pandemic hopefully in our rearview mirror, we are left with most patients emerging with varying […]

Continue Reading

Getting Back to Work

Getting Back to Work

| June 1, 2021

by John M. Morton, MD, MPH, MHA, FACS, FASMBS, ABOM Clinical Editor of Bariatric Times; Vice-Chair of Quality and Division Chief of Bariatric and Minimally Invasive Surgery in the Department of Surgery at Yale School of Medicine in New Haven, Connecticut. Dear Friends and Readers, As we watch COVID-19 cases plummet and vaccinations surge, I […]

Continue Reading

Semaglutide 2.4mg—One Giant STEP for Obesity Treatment??

Semaglutide 2.4mg—One Giant STEP for Obesity Treatment??

| June 1, 2021

by Christopher D. Still, DO, FACN, FACP Co-clinical Editor of Bariatric Times; Medical Director for the Center for Nutrition and Weight Management, and Director for Geisinger Obesity Research Institute at Geisinger Medical Center in Danville, Pennsylvania. Dear Colleagues, This is a very exciting time for clinicians treating obesity. Expected soon is the United States Food […]

Continue Reading